Novartis Said to Near $70-Per-Share-Plus Deal for Avidity
Novartis AG is nearing a deal to buy biotechnology company Avidity Biosciences Inc., according to a person familiar with the…
Novartis AG is nearing a deal to buy biotechnology company Avidity Biosciences Inc., according to a person familiar with the…